The global pharmaceutical gelatin market size is expected to reach USD 2.17 billion by 2032, according to a new study by Polaris Market Research. The report “Pharmaceutical Gelatin Market Share, Size, Trends, Industry Analysis Report, By Surce (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry); By Function; By End Use; By Regions; Segment Forecast, 2022 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Pharmaceutical gelatin is a high molecular weight, delicate, water-soluble, colorless, and translucent substance obtained from the partial hydrolysis of collagen found in animal skin, bones, and white connective tissues. It is a non-toxic and absorbable substance extensively utilized in various pharmaceutical applications. Gelatin is commonly used as a suspending agent to stabilize pharmaceutical suspensions and produce capsules. Furthermore, it is an excellent source of protein and can be used as a substitute for plasma.
In surgical procedures, absorbable film and sponges contain gelatin. The gelatin market is driven by the increasing use of gelatin in the nutraceutical and pharmaceutical industries for manufacturing drugs, growing awareness of the importance of nutrition-rich foods, and the expanding senior population. However, the high cost of gelatin, which is heavily used in the outer covering of capsules, and the availability of substitute components hinder the market growth. Furthermore, the rising awareness of nutrition fortification in food presents an opportunity for future growth in this market.
Several opportunities for market expansion exist due to the major market participants enhanced efforts to create distinctive gelatin capsule shells employing cutting-edge technology. For example, a digital health company, etectRx, Inc., has been conducting studies to track medication opioid users' observation with antiretroviral treatment while handling human immunodeficiency virus (HIV). In the "MyTPill" project, patient adherence will be evaluated using the System ID-Cap, which comprises a capsule of hard gelatin with the wireless detector of an ingestible and a wearable reader. These unprecedented steps will increase the use of gelatin in producing hard gelatin capsules (ID-Cap), accelerating market growth.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/pharmaceutical-gelatin-market/request-for-sample
The production and supply chain of gelatin were significantly affected by COVID-19 as the import and export of gelatin-based products and capsules were suspended due to pandemic restrictions. Notably, gelatin was found to play a vital role in COVID-19 treatment. For example, a PubMed study published in May 2022 revealed that adding gelatin to drug delivery considerably improves protein stabilization and enhances the active protein fractions after nebulization, thus reducing medication dosages. In the post-pandemic era, the market is expected to experience growth due to increased product launches, higher demand for pharmaceutical-grade gelatin, and increased research and development in gelatin-based products.
Polaris Market Research has segmented the Pharmaceutical Gelatin Market report based on source, function, end-use, and region:
Pharmaceutical Gelatin Market, Source Outlook (Revenue - USD Billion, 2019 - 2032)
Pharmaceutical Gelatin Market, Function Outlook (Revenue - USD Billion, 2019 - 2032)
Pharmaceutical Gelatin Market, End-Use Outlook (Revenue - USD Billion, 2019- 2032)
Pharmaceutical Gelatin Market, Regional Outlook (Revenue - USD Billion, 2019 - 2032)